# Efficacy And Safety Of Probiatop In The Treatment Of Digestive Symptoms

> **NCT05603403** · PHASE4 · COMPLETED · sponsor: **Azidus Brasil** · enrollment: 150 (actual)

## Conditions studied

- Signs and Symptoms, Digestive

## Interventions

- **DRUG:** Probiatop
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05603403
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-20
- **Primary completion:** 2023-03-15
- **Final completion:** 2023-03-15
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2024-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05603403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05603403, "Efficacy And Safety Of Probiatop In The Treatment Of Digestive Symptoms". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05603403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*